399 related articles for article (PubMed ID: 15448164)
1. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine.
Chang TS; Jeong W; Woo HA; Lee SM; Park S; Rhee SG
J Biol Chem; 2004 Dec; 279(49):50994-1001. PubMed ID: 15448164
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin.
Jeong W; Park SJ; Chang TS; Lee DY; Rhee SG
J Biol Chem; 2006 May; 281(20):14400-7. PubMed ID: 16565085
[TBL] [Abstract][Full Text] [Related]
3. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins.
Woo HA; Jeong W; Chang TS; Park KJ; Park SJ; Yang JS; Rhee SG
J Biol Chem; 2005 Feb; 280(5):3125-8. PubMed ID: 15590625
[TBL] [Abstract][Full Text] [Related]
4. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.
Rhee SG; Jeong W; Chang TS; Woo HA
Kidney Int Suppl; 2007 Aug; (106):S3-8. PubMed ID: 17653208
[TBL] [Abstract][Full Text] [Related]
5. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin.
Jönsson TJ; Tsang AW; Lowther WT; Furdui CM
J Biol Chem; 2008 Aug; 283(34):22890-4. PubMed ID: 18593714
[TBL] [Abstract][Full Text] [Related]
6. Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.
Noh YH; Baek JY; Jeong W; Rhee SG; Chang TS
J Biol Chem; 2009 Mar; 284(13):8470-7. PubMed ID: 19176523
[TBL] [Abstract][Full Text] [Related]
7. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate.
Jönsson TJ; Murray MS; Johnson LC; Lowther WT
J Biol Chem; 2008 Aug; 283(35):23846-51. PubMed ID: 18579529
[TBL] [Abstract][Full Text] [Related]
8. Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin.
Lowther WT; Haynes AC
Antioxid Redox Signal; 2011 Jul; 15(1):99-109. PubMed ID: 20712415
[TBL] [Abstract][Full Text] [Related]
9. The Arabidopsis thaliana sulfiredoxin is a plastidic cysteine-sulfinic acid reductase involved in the photooxidative stress response.
Rey P; Bécuwe N; Barrault MB; Rumeau D; Havaux M; Biteau B; Toledano MB
Plant J; 2007 Feb; 49(3):505-14. PubMed ID: 17217469
[TBL] [Abstract][Full Text] [Related]
10. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver.
Bae SH; Sung SH; Cho EJ; Lee SK; Lee HE; Woo HA; Yu DY; Kil IS; Rhee SG
Hepatology; 2011 Mar; 53(3):945-53. PubMed ID: 21319188
[TBL] [Abstract][Full Text] [Related]
11. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin.
Park JW; Mieyal JJ; Rhee SG; Chock PB
J Biol Chem; 2009 Aug; 284(35):23364-74. PubMed ID: 19561357
[TBL] [Abstract][Full Text] [Related]
12. Evolution of eukaryotic cysteine sulfinic acid reductase, sulfiredoxin (Srx), from bacterial chromosome partitioning protein ParB.
Basu MK; Koonin EV
Cell Cycle; 2005 Jul; 4(7):947-52. PubMed ID: 15917647
[TBL] [Abstract][Full Text] [Related]
13. Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins.
Woo HA; Bae SH; Park S; Rhee SG
Antioxid Redox Signal; 2009 Apr; 11(4):739-45. PubMed ID: 19113821
[TBL] [Abstract][Full Text] [Related]
14. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin.
Biteau B; Labarre J; Toledano MB
Nature; 2003 Oct; 425(6961):980-4. PubMed ID: 14586471
[TBL] [Abstract][Full Text] [Related]
15. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression.
Jeong W; Bae SH; Toledano MB; Rhee SG
Free Radic Biol Med; 2012 Aug; 53(3):447-56. PubMed ID: 22634055
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin.
Jönsson TJ; Murray MS; Johnson LC; Poole LB; Lowther WT
Biochemistry; 2005 Jun; 44(24):8634-42. PubMed ID: 15952770
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis and modeling of the peroxiredoxin (Prx) complex with the NMR structure of ATP-bound human sulfiredoxin implicate aspartate 187 of Prx I as the catalytic residue in ATP hydrolysis.
Lee DY; Park SJ; Jeong W; Sung HJ; Oho T; Wu X; Rhee SG; Gruschus JM
Biochemistry; 2006 Dec; 45(51):15301-9. PubMed ID: 17176052
[TBL] [Abstract][Full Text] [Related]
18. Irreversible oxidation of the active-site cysteine of peroxiredoxin to cysteine sulfonic acid for enhanced molecular chaperone activity.
Lim JC; Choi HI; Park YS; Nam HW; Woo HA; Kwon KS; Kim YS; Rhee SG; Kim K; Chae HZ
J Biol Chem; 2008 Oct; 283(43):28873-80. PubMed ID: 18725414
[TBL] [Abstract][Full Text] [Related]
19. Protein engineering of the quaternary sulfiredoxin.peroxiredoxin enzyme.substrate complex reveals the molecular basis for cysteine sulfinic acid phosphorylation.
Jönsson TJ; Johnson LC; Lowther WT
J Biol Chem; 2009 Nov; 284(48):33305-10. PubMed ID: 19812042
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid.
Yang KS; Kang SW; Woo HA; Hwang SC; Chae HZ; Kim K; Rhee SG
J Biol Chem; 2002 Oct; 277(41):38029-36. PubMed ID: 12161445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
